The Technical Analyst
Enfusion, Inc. [ENFN]
Exchange: NYSE Sector: Technology Industry: Software—Application
Enfusion, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-6.14% $9.17
America/New_York / 9 mai 2024 @ 13:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 833.34 mill |
| EPS: | 0.0700 |
| P/E: | 131.00 |
| Earnings Date: | May 09, 2024 |
| SharesOutstanding: | 90.88 mill |
| Avg Daily Volume: | 0.419 mill |
| RATING 2024-05-09 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 9.92x |
| Company: PE 131.00 | sector: PE 13.21 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.38x |
| Company: PE 131.00 | industry: PE 346.95 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$1.865 (-79.66%) $-7.30 |
| Date: 2024-05-09 |
| Expected Trading Range (DAY) |
|---|
|
$ 8.90 - 9.48 ( +/- 3.14%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-05 | Movchan Oleg | Buy | 149 701 | Class A Common Stock |
| 2024-03-05 | Movchan Oleg | Buy | 100 000 | Class A Common Stock |
| 2024-03-01 | Movchan Oleg | Buy | 13 887 | Class A Common Stock |
| 2024-03-01 | Movchan Oleg | Sell | 4 069 | Class A Common Stock |
| 2024-03-01 | Pawar Neal | Buy | 144 176 | Class A Common Stock |
| INSIDER POWER |
|---|
| 10.71 |
| Last 99 transactions |
| Buy: 4 242 931 | Sell: 3 488 116 |
Forecast:
14:41 - $9.07
Live Trading Signals (every 1 min)
Forecast
1: 13:11 - $9.18
Forecast 2: 14:01 - $9.18
Forecast 3: 14:41 - $9.07
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $9.17 (-6.14% ) |
| Volume | 0.231 mill |
| Avg. Vol. | 0.419 mill |
| % of Avg. Vol | 55.22 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ENFN
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
ENFN
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
Latest Press Releases
2024-04-18 08:30:00 - Press Release
Enfusion Announces Date Of First Quarter 2024 Results
New york & london & hong kong--(business wire)--enfusion, inc. ("enfusion") (nyse: enfn), a leading provider of software-as-a-service (saas) solutions for investment managers, today announced it will release its first quarter 2024 financial results before the u.s. financial markets open on thursday, may 9, 2024. management will host a conference call and webcast that same morning at 5:30 am (pt) / 8:30 am (et) to discuss the results. to access this call, dial (888) 596-4144. the conference id n.
2024-04-12 14:40:00 - Press Release
Shareholder Alert: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Enfusion, Inc. - Enfn
New york , april 12, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of enfusion, inc. ("enfusion" or the "company") (nyse: enfn). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.
2024-04-04 19:15:00 - Press Release
Shareholder Alert: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Enfusion, Inc. - Enfn
New york , april 4, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of enfusion, inc. ("enfusion" or the "company") (nyse: enfn). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.
2024-04-02 07:30:00 - Press Release
Connexpay Appoints Ben Peters As Chief Executive Officer
Atlanta--(business wire)-- #simplyconnectingpayments--connexpay has announced the appointment of ben peters as chief executive officer. peters brings more than two decades of experience.
2024-03-27 17:25:00 - Press Release
Shareholder Alert: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Enfusion, Inc. - Enfn
New york , march 27, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of enfusion, inc. ("enfusion" or the "company") (nyse: enfn). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.
Latest News
2024-05-09 10:36:48 - Zacks Investment Research
Enfusion (ENFN) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Enfusion (ENFN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
2024-04-18 08:30:00 - Business Wire
Enfusion Announces Date of First Quarter 2024 Results
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its first quarter 2024 financial results before the U.S. financial markets open on Thursday, May 9, 2024. Management will host a conference call and webcast that same morning at 5:30 AM (PT) / 8:30 AM (ET) to discuss the results. To access this call, dial (888) 596-4144. The conference ID n.
2024-03-31 11:20:54 - Seeking Alpha
Enfusion: TAM Penetration Continues To Progress Well
ENFN reported solid Q4 earnings with accelerating revenue growth and a strong pipeline. The company is successfully penetrating the total addressable market (TAM) in the asset management industry. ENFN's focus on product innovation and total cost of ownership (TCO) advantage will drive future growth and close the valuation gap with peers.
2024-03-15 06:00:00 - InvestorPlace
Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024
Finding undervalued stocks is one of the key elements to making successful investments. Undervalued stocks are those that trade below their intrinsic value, meaning that the market has not fully recognized their “true potential.
2024-03-12 12:50:06 - Seeking Alpha
Enfusion, Inc. (ENFN) Q4 2023 Earnings Call Transcript
2024-03-12 11:00:20 - Zacks Investment Research
Enfusion, Inc. (ENFN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Enfusion, Inc. (ENFN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
2024-03-12 10:46:11 - Zacks Investment Research
Enfusion, Inc. (ENFN) Lags Q4 Earnings Estimates
Enfusion, Inc. (ENFN) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.03 per share a year ago.
2024-01-18 01:28:12 - Seeking Alpha
Enfusion: Product Is Sticky And Industry Is Huge
I am recommending a buy rating as I see room for ENFN to grow and visible catalysts for growth acceleration. The company provides an end-to-end SaaS solution for investment managers, making it a sticky product with high pricing power. The industry is large and healthy, with ample opportunities for Enfusion to expand its market share.
2023-11-11 16:30:07 - Seeking Alpha
Enfusion, Inc. (ENFN) Q3 2023 Earnings Call Transcript
Enfusion, Inc. (NYSE:ENFN ) Q3 2023 Results Conference Call November 7, 2023 8:30 AM ET Company Participants Ignatius Njoku - Head, IR Oleg Movchan - CEO Brad Herring - CFO Conference Call Participants Michael Infante - Morgan Stanley Faith Brunner - William Blair Elyse Kanner - JPMorgan Parker Lane - Stifel Crispin Love - Piper Sandler Callie Valenti - Goldman Sachs Natalie Howe - Bank of America Operator Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Enfusion's Third Quarter 2023 Earnings Conference Call.
2023-11-08 02:22:50 - Seeking Alpha
Enfusion: Still Bullish Considering Q3 EBITDA Beat
Enfusion's EBITDA expanded by +48% YoY in Q3 2023, which was +6% better than what the market had expected. ENFN's long-term prospects are favorable, taking into account the room for revenue growth and profit margin improvement. I retain a Buy rating for ENFN stock, in consideration of its good recent quarterly results and positive financial outlook.